Entry Detail



General Information

Database ID:exR0763173
RNA Name:RPS11
RNA Type:mRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):49496365End Site(bp):49499708
External Links:ENSG00000142534



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC245033.1
chr15
82536788
82573194
-
ADCY1
chr7
45574140
45723116
+
ADAR
chr1
154582057
154628013
-
AK2
chr1
33007940
33080996
-
ADGRL1
chr19
14147743
14206187
-
ADH5
chr4
99070978
99088801
-
AC131160.1
chr3
183815568
183884889
-
AAGAB
chr15
67200667
67255195
-
ACTG1
chr17
81509971
81523847
-
AL138752.2
chr9
37588413
38068687
-
ABCE1
chr4
145098288
145129524
+
AIP
chr11
67483026
67491103
+
AC010422.3
chr19
12643831
12648397
-
AC099811.2
chr17
42119674
42154916
-
AC079594.2
chr3
160227454
160449829
-
AL603832.3
chr1
112702614
112711433
-
ABHD18
chr4
127965306
128039927
+
ADGRL2
chr1
81306160
81992436
+
AC138811.2
chr16
18788063
18801519
-
AKIRIN1
chr1
38991276
39006059
+
AL162231.3
chr9
34646645
34657113
+
ALDH18A1
chr10
95605941
95656711
-
AC004922.1
chr7
99325879
99394653
+
ACSS2
chr20
34872146
34927962
+
AC007192.1
chr19
18153158
18178117
+
AC005258.1
chr19
2269525
2341172
+
ADAM10
chr15
58588809
58749791
-
AFDN
chr6
167826922
167972023
+
AL133352.1
chr10
100505628
100529881
-
ALDOA
chr16
30064164
30070457
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-210-3p
chr11
568112
568133
-
hsa-miR-632
chr17
32350169
32350187
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC010624.2
chr19
50075123
50075902
+
AC108134.2
chr16
3156736
3157483
-
AD000090.1
chr19
35557956
35581954
+
AL117378.1
chr6
131901963
131920565
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.